Article Text

Download PDFPDF
PWE-025 Comparing quality of life in coeliac disease and inflammatory bowel disease: a paradigm shift in our perceptions?
  1. S M Barratt,
  2. J S Leeds,
  3. A J Lobo,
  4. M E Mcalindon,
  5. K Robinson,
  6. H Wilson,
  7. S Lin,
  8. D S Sanders
  1. The GI and Liver Unit, The Royal Hallamshire Hospital, Sheffield, UK


Introduction The Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36) is a valid and reliable quality of life (QoL) measure in coeliac disease and inflammatory bowel disease (IBD). However, there has never been a study to compare the QoL of individuals with these two diseases. We hypothesised that individuals with IBD report a worse QoL than those individuals with coeliac disease because IBD is considered to be the more severe disease of the two.1

Methods A postal survey (n=1031) of patients with histologically proven Coeliac Disease (n=225), Crohn's disease (CD) (n=230) and ulcerative colitis (UC) (n=228). We also recruited non-health-seeking age and sex matched controls (n=348). Questionnaire included SF-36, Hospital Anxiety and Depression Scale (HADS), ROME II criteria for Irritable Bowel Syndrome (IBS) and a reflux oesophagitis (RO) screen. Disease-specific assessment included disease duration and either the Harvey-Bradshaw Activity Index (HBI), Simple Colitis Activity Index (SCAI) or assessment of gluten-free diet (GFD) adherence.

Result Disease duration had a negligible impact on responses in CD, UC and Coeliac Disease (p=ns). At least one RO symptom was reported by 66% of Coeliac Disease respondents, 72% of CD, 62% of UC and 50% of controls. We found stepwise reductions in all respondents' SF-36 scores and increases in HADS-A and HADS-D scores with increasing RO symptom severity (p=<0.05). 22% of Coeliac Disease respondents, 24% of CD, 16% of UC and 6% of controls met ROME II criteria for IBS, which also reduced respondent wellbeing in all groups (p=<0.0001) (Abstract 025).

Abstract PWE-025

Overall group comparison of SF-36 and HADS scores

Conclusion This is the first study to report that CD patients experience the worst QoL but surprisingly Coeliac Disease patients had a worse QoL and increased risk of anxiety and depression than UC (p=<0.0001). In addition we observed that both RO and IBS further reduce patient QoL and increase the risk of anxiety and depression.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.